Meribank Biotech Co (ROCO:4724) FCF Margin % : -14.44% (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Meribank Biotech Co's Free Cash Flow for the six months ended in Dec. 2023 was NT$-19.0 Mil. Meribank Biotech Co's Revenue for the six months ended in Dec. 2023 was NT$131.3 Mil. Therefore, Meribank Biotech Co's FCF Margin % for the quarter that ended in Dec. 2023 was -14.44%.

As of today, Meribank Biotech Co's current FCF Yield % is -1.38%.

The historical rank and industry rank for Meribank Biotech Co's FCF Margin % or its related term are showing as below:

ROCO:4724' s FCF Margin % Range Over the Past 10 Years
Min: -25.3 Med: -14.26 Max: -2.17
Current: -15.52

During the past 6 years, the highest FCF Margin % of Meribank Biotech Co was -2.17%. The lowest was -25.30%. And the median was -14.26%.

ROCO:4724's FCF Margin % is ranked better than
70.55% of 1046 companies
in the Biotechnology industry
Industry Median: -141.025 vs ROCO:4724: -15.52

Meribank Biotech Co FCF Margin % Historical Data

The historical data trend for Meribank Biotech Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co FCF Margin % Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-6.11

-13.00

-18.71

-25.30

-15.52

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial							-13.97	-23.91	-26.39	-16.91	-14.44

Competitive Comparison of Meribank Biotech Co's FCF Margin %

For the Biotechnology subindustry, Meribank Biotech Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meribank Biotech Co's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Meribank Biotech Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Meribank Biotech Co's FCF Margin % falls into.

Meribank Biotech Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Meribank Biotech Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-36.377	/	234.342
	=	-15.52 %

Meribank Biotech Co's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-18.952	/	131.28
	=	-14.44 %

Meribank Biotech Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines